Compound Q&A
What is the market or research trend for lasofoxifene tartrate (CAS: 190791-29-8)?
Answer
The market for lasofoxifene tartrate (CAS: 190791-29-8) is primarily driven by its use as a selective estrogen receptor modulator (SERM) in the treatment of osteoporosis and menopausal symptoms. Research trends are focused on understanding its pharmacokinetics, therapeutic efficacy, and potential side effects. Recent studies are also exploring its role in preventing bone loss and its safety profile in different patient populations.
About
CAS No
190791-29-8
English Name
Lasofoxifene tartrate
Molecular Formula
C32H37NO8
Molecular Weight
563.65 g/mol
SMILES
C1CCN(C1)CCOC2=CC=C(C=C2)C3C(CCC4=C3C=CC(=C4)O)C5=CC=CC=C5.C(C(C(=O)O)O)(C(=O)O)O
InChIKey
INEHJXCWEVNEDZ-LUDNRVPPSA-N
Last Updated: 2025-10-26 19:35
